85 related articles for article (PubMed ID: 26208847)
1. Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum.
Takahashi S; Kohashi K; Yamamoto H; Hirahashi M; Kumagai R; Takizawa N; Nakamura K; Maehara Y; Tanaka M; Takayanagi R; Oda Y
Hum Pathol; 2015 Sep; 46(9):1257-66. PubMed ID: 26208847
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
4. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
[TBL] [Abstract][Full Text] [Related]
5. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer.
Jang TJ
Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145
[TBL] [Abstract][Full Text] [Related]
6. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
[TBL] [Abstract][Full Text] [Related]
7. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
[TBL] [Abstract][Full Text] [Related]
8. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics.
Rüschoff J; Dietmaier W; Lüttges J; Seitz G; Bocker T; Zirngibl H; Schlegel J; Schackert HK; Jauch KW; Hofstaedter F
Am J Pathol; 1997 May; 150(5):1815-25. PubMed ID: 9137104
[TBL] [Abstract][Full Text] [Related]
9. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
[TBL] [Abstract][Full Text] [Related]
10. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
[TBL] [Abstract][Full Text] [Related]
11. Medullary carcinoma in the colorectum: a systematic review and meta-analysis.
Pyo JS; Sohn JH; Kang G
Hum Pathol; 2016 Jul; 53():91-6. PubMed ID: 27001432
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
13. Medullary carcinoma of the large intestine: a population based analysis.
Thirunavukarasu P; Sathaiah M; Singla S; Sukumar S; Karunamurthy A; Pragatheeshwar KD; Lee KK; Zeh H; Kane KM; Bartlett DL
Int J Oncol; 2010 Oct; 37(4):901-7. PubMed ID: 20811712
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma.
García-Solano J; Conesa-Zamora P; Trujillo-Santos J; Torres-Moreno D; Mäkinen MJ; Pérez-Guillermo M
Hum Pathol; 2012 Jul; 43(7):1094-102. PubMed ID: 22209340
[TBL] [Abstract][Full Text] [Related]
15. The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancer.
Bhangu A; Wood G; Brown G; Darzi A; Tekkis P; Goldin R
Colorectal Dis; 2014 Apr; 16(4):O133-43. PubMed ID: 24617665
[TBL] [Abstract][Full Text] [Related]
16. Poorly Differentiated Clusters in Colorectal Adenocarcinomas Share Biological Similarities with Micropapillary Patterns as well as Tumor Buds.
Hong M; Kim JW; Shin MK; Kim BC
J Korean Med Sci; 2017 Oct; 32(10):1595-1602. PubMed ID: 28875602
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
[TBL] [Abstract][Full Text] [Related]
18. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival.
Lanza G; Gafà R; Matteuzzi M; Santini A
J Clin Oncol; 1999 Aug; 17(8):2429-38. PubMed ID: 10561306
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]